ID   CBTCi004-A
AC   CVCL_WJ47
SY   EB14
DR   hPSCreg; CBTCi004-A
DR   Wikidata; Q93444608
RX   PubMed=31078962;
CC   From: Centro de Biotecnologia e Terapia Celular, Hospital Sao Rafael; Salvador; Brazil.
CC   Population: Afro-Brazilian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
RX   PubMed=31078962; DOI=10.1016/j.scr.2019.101454;
RA   Paredes B.D., Martins G.L.S., Azevedo C.M., Sampaio G.L.A.,
RA   Nonaka C.K.V., da Silva K.N., Soares M.B.P., dos Santos R.R.,
RA   de Freitas Souza B.S.;
RT   "Generation of three control iPS cell lines for sickle cell disease
RT   studies by reprogramming erythroblasts from individuals without
RT   hemoglobinopathies.";
RL   Stem Cell Res. 38:101454-101454(2019).
//